View in EDS

Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.

Saved in:
Bibliographic Details
Title: Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
Authors: Kirkwood JM; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. kirkwoodjm@upmc.edu., Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Weber J; NYU Langone Medical Center, New York, NY, USA., Hoeller C; Medizinische Universität Wien, Vienna, Austria., Grob JJ; Hôpital de la Timone, Marseille, France., Mohr P; Elbe Klinikum Buxtehude, Buxtehude, Germany., Loquai C; University Medical Center Mainz, Mainz, Germany., Dutriaux C; Hôpital Saint André, Bordeaux, France., Chiarion-Sileni V; Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy., Mackiewicz J; Institute of Oncology, Poznan University of Medical Sciences, Poznan, Poland., Rutkowski P; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Arenberger P; Charles University Third Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic., Quereux G; Nantes University Hospital, Nantes, France., Meniawy TM; University of Western Australia and Sir Charles Gairdner Hospital, Perth, WA, Australia., Ascierto PA; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Menzies AM; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Durani P; Bristol Myers Squibb, Princeton, NJ, USA., Lobo M; Bristol Myers Squibb, Princeton, NJ, USA., Campigotto F; Bristol Myers Squibb, Princeton, NJ, USA., Gastman B; Cleveland Clinic, Cleveland, OH, USA., Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
Source: Nature medicine [Nat Med] 2024 Mar; Vol. 30 (3), pp. 906.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38177857
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kirkwood+JM%22">Kirkwood JM</searchLink>; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. kirkwoodjm@upmc.edu.<br /><searchLink fieldCode="AU" term="%22Del+Vecchio+M%22">Del Vecchio M</searchLink>; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Weber+J%22">Weber J</searchLink>; NYU Langone Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hoeller+C%22">Hoeller C</searchLink>; Medizinische Universität Wien, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Grob+JJ%22">Grob JJ</searchLink>; Hôpital de la Timone, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Mohr+P%22">Mohr P</searchLink>; Elbe Klinikum Buxtehude, Buxtehude, Germany.<br /><searchLink fieldCode="AU" term="%22Loquai+C%22">Loquai C</searchLink>; University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Dutriaux+C%22">Dutriaux C</searchLink>; Hôpital Saint André, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Chiarion-Sileni+V%22">Chiarion-Sileni V</searchLink>; Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Mackiewicz+J%22">Mackiewicz J</searchLink>; Institute of Oncology, Poznan University of Medical Sciences, Poznan, Poland.<br /><searchLink fieldCode="AU" term="%22Rutkowski+P%22">Rutkowski P</searchLink>; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Arenberger+P%22">Arenberger P</searchLink>; Charles University Third Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Quereux+G%22">Quereux G</searchLink>; Nantes University Hospital, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Meniawy+TM%22">Meniawy TM</searchLink>; University of Western Australia and Sir Charles Gairdner Hospital, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Ascierto+PA%22">Ascierto PA</searchLink>; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Durani+P%22">Durani P</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lobo+M%22">Lobo M</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Campigotto+F%22">Campigotto F</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Gastman+B%22">Gastman B</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2024 Mar; Vol. 30 (3), pp. 906.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38177857
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-023-02775-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 906
    Titles:
      – TitleFull: Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kirkwood JM
      – PersonEntity:
          Name:
            NameFull: Del Vecchio M
      – PersonEntity:
          Name:
            NameFull: Weber J
      – PersonEntity:
          Name:
            NameFull: Hoeller C
      – PersonEntity:
          Name:
            NameFull: Grob JJ
      – PersonEntity:
          Name:
            NameFull: Mohr P
      – PersonEntity:
          Name:
            NameFull: Loquai C
      – PersonEntity:
          Name:
            NameFull: Dutriaux C
      – PersonEntity:
          Name:
            NameFull: Chiarion-Sileni V
      – PersonEntity:
          Name:
            NameFull: Mackiewicz J
      – PersonEntity:
          Name:
            NameFull: Rutkowski P
      – PersonEntity:
          Name:
            NameFull: Arenberger P
      – PersonEntity:
          Name:
            NameFull: Quereux G
      – PersonEntity:
          Name:
            NameFull: Meniawy TM
      – PersonEntity:
          Name:
            NameFull: Ascierto PA
      – PersonEntity:
          Name:
            NameFull: Menzies AM
      – PersonEntity:
          Name:
            NameFull: Durani P
      – PersonEntity:
          Name:
            NameFull: Lobo M
      – PersonEntity:
          Name:
            NameFull: Campigotto F
      – PersonEntity:
          Name:
            NameFull: Gastman B
      – PersonEntity:
          Name:
            NameFull: Long GV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2024 Mar
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1